• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
4
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

The spectrum of gluten related diseases

Nijeboer, P.

2017

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Nijeboer, P. (2017). The spectrum of gluten related diseases: diagnosis, epidemiology and treatment.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

Part VI

(3)

2-CDA Cladribine (2-clorodeoxyadenosine) ACD Active celiac disease

alloSCT Allogeneic stem cell transplantation

APC Allophycocyanin

ATI α-amylase/trypsin inhibitor

AUC Area under the curve

auSCT Autologous hematopoietic stem cell transplantation auto-SCT Autologous hematopoietic stem cell transplantation BMI Body mass index

CD Celiac disease

CHOP Cyclophosphamide, doxorubicin, vincristin and prednisolone CT Computed tomography

CVID Common-variable immunodeficiency syndrome DBE Double balloon enteroscopy

DC Disease controls

DGP Deamidated gliadin peptides

EATL Enteropathy associated T-cell Lymphoma

EMA Endomysium antibodies

FFM Fat-free mass

FFMI Fat-free mass index

FITC Fluorescein isothiocyanate

FM Fat mass

FODMAPs Fermentable oligo-, di-, monosaccharides, and polyols

FWW Feces wet weight GCD Gluten-containing diet

GFD Gluten-free diet

GM-CSF Granulocyte-macrophage colony stimulating factor HGS Handgrp strength

HR Hazard ratio

γδ+ IEL Gamma-delta intraepithelial lymphocytes IBS Irritable bowel syndrome

iCD3 Intracellular CD3 expression ICU Intensive care unit

IEL Intra-epithelial lymphocytes IFN-γ interferon gamma

(4)

IPI International prognostic index mAbs Monoclonal antibodies

MHC Major histocompatibility complex

MRE Magnetic resonance imaging enteroclysis NCGS Non-celiac gluten sensitivity

NCWS Non-celiac wheat sensitivity OR Odds ratio

OS Overall survival

PBMC Peripheral blood mononuclear cell

PCD Potential celiac disease

PE Phycoerythrin

PerCP Peridinin chlorophyll protein

PET-scan Positron Emissie Tomografie scan

RCD Refractory celiac disease RCDI Refractory celiac disease type I RCDII Refractory celiac disease type II REE Resting energy expenditure

ROC curve Receiver operating characteristic curve sCD3 Surface CD3 expression

sCD3-iCD3+ IEL Surface CD3 negative and intracellular CD3 positive lymphocytes SCT Stem-cell transplantation

SD standard deviation

srGS Self-reported gluten-sensitivity TCR T cell receptor

TCR- γδ Gamma delta T-cell antigen receptor

TEE Total energy expenditure TEI Total dietary energy intake

TGA Tissue transglutaminase antibodies

TLR2 Toll-like receptor 2

TNF-α Tumor necrosis factor alpha

UJ Ulcerative jejunitis

VAS Visual analoque score

VCE Videocapsule enteroscopy

WGA Wheat Germ Agglutinin

Referenties

GERELATEERDE DOCUMENTEN

The analyses con firmed the same systematic and stepwise effects of donor type on the cumulative excess event rates in overall survival, non-relapse mortality and relapse-free

1 Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, the Netherlands; 2 Van CreveldKliniek, University Medical Center

(a) The T-cell receptor excision circle (TREC) content of total CD4 + T-cells, measured in patients in clinical remission (n = 36, all triangles [Table 1]), is heterogeneous,

Three out of four main dimensions of the generic measure SF-36, except for the dimension of well-being, showed significant improvements in health status scores compared to

Chapter 5 reports the effects of high dose chemotherapy and autologous stem cell transplantation (HDC + ASCT) on j oint damage in patients with severe rheumatoid arthritis

Long term follow-up of health status in patients with severe rheumatoid arthritis after high dose chemotherapy followed by autologous stem

The author wishes to express his gratitude to all co-workers of the Departments of Rheumatology, Haematology and Medical Decision Making of the Leiden University Medical Center.

Indien de aan de behandeling gerelateerde mortaliteit minder dan 3.3% is, geniet hoge dosis chemotherapie en autologe hematopoïetische stamcel transplantatie de voorkeur